BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2313491)

  • 1. Highlights of Good Manufacturing Practice in Japan.
    Morita K
    J Parenter Sci Technol; 1990; 44(1):35-8. PubMed ID: 2313491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical GMP: past, present, and future--a review.
    Patel KT; Chotai NP
    Pharmazie; 2008 Apr; 63(4):251-5. PubMed ID: 18468382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmaceutical product quality control and good manufacturing practices].
    Hiyama Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2010; (128):1-16. PubMed ID: 21381389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carleton's corner. Should the United States pharmacopeia define manufacturing process limits?
    Korczynski MS
    J Parenter Sci Technol; 1991; 45(2):76. PubMed ID: 2051259
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmaceutical quality and good manufacturing practices (author's transl)].
    Traisnel
    J Pharm Belg; 1980; 35(3):233-7. PubMed ID: 7400928
    [No Abstract]   [Full Text] [Related]  

  • 8. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of Current Good Manufacturing Practices in a small research laboratory setting.
    Keller CD; Taulbee SM
    Qual Assur; 1995 Mar; 4(1):83-6. PubMed ID: 8520870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Accession to the PIC/S and pharmaceutical quality system in Japan].
    Katori N
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2014; (132):22-35. PubMed ID: 25707200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Manufacturing and control in pharmaceutical industry. Introduction into manufacturing control. Introduction].
    Hippenmeier F
    Pharm Acta Helv; 1972; 47(11):625-8. PubMed ID: 4657531
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA initiative will enhance drug good manufacturing practices.
    FDA Consum; 2002; 36(6):4. PubMed ID: 12523283
    [No Abstract]   [Full Text] [Related]  

  • 13. Strengthening drug manufacturing practices.
    Hecht A
    FDA Consum; 1976; 10(6):12-4. PubMed ID: 829227
    [No Abstract]   [Full Text] [Related]  

  • 14. Developing a tool for the preparation of GMP audit of pharmaceutical contract manufacturer.
    Linna A; Korhonen M; Mannermaa JP; Airaksinen M; Juppo AM
    Eur J Pharm Biopharm; 2008 Jun; 69(2):786-92. PubMed ID: 18191391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 16. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDA response. FDA advance notice of proposed rulemaking on electronic identification/signatures. Parenteral Drug Association.
    J Parenter Sci Technol; 1993; 47(1):4-8. PubMed ID: 8445499
    [No Abstract]   [Full Text] [Related]  

  • 18. Disinfectants as an aid for good manufacturing practice in the pharmaceutical industry.
    Wallhäusser KH
    J Pharm Belg; 1981; 36(5):283-97. PubMed ID: 7310623
    [No Abstract]   [Full Text] [Related]  

  • 19. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Dec; 72(232):68064-70. PubMed ID: 18064770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.